About us
Overview
Our strategy
Our leadership
How we’re funded
Our history
What we do
Overview
Our science
Therapeutics
Diagnostics development
Partnering with us
Funding, projects and partnerships
Available technologies
LifeArc Ventures
IP management and tech transfer
Policy and public affairs
Translational Challenges
Overview
Motor Neuron Disease
Chronic Respiratory Infection
Global Health
Antimicrobial Resistance
Neglected Tropical Diseases
Emerging Viral Threats
Rare Disease
Childhood Cancer
News and events
News
Events
Careers
Overview
Benefits and rewards
Early careers
Current vacancies
Contact us
Search
Toggle Menu
Search
Search
Search
Refine results
Content Type
Case Studies
Diagnostics
Events
Other Technologies
Pages
People
Posts
Publications
Therapeutics
Topic
Company updates
Motor neuron disease
Chronic respiratory infection
Global health
Rare disease
Childhood cancer
Neurodegeneration
Technology transfer
Our science
Ventures funding
LifeArc Ventures
Page
18 December 2023
Read more
: LifeArc Ventures
IP management and technology transfer
Page
18 December 2023
Read more
: IP management and technology transfer
Partnering with us
Page
18 December 2023
Read more
: Partnering with us
Our science
Page
18 December 2023
Read more
: Our science
Childhood Cancer
Page
18 December 2023
Read more
: Childhood Cancer
Rare Disease
Page
18 December 2023
Read more
: Rare Disease
Neurodegeneration
Page
18 December 2023
Read more
: Neurodegeneration
Global Health
Page
18 December 2023
Read more
: Global Health
Emerging Viral Threats
Page
18 December 2023
Read more
: Emerging Viral Threats
Neglected Tropical Diseases
Page
18 December 2023
Read more
: Neglected Tropical Diseases
Antimicrobial Resistance
Page
18 December 2023
Read more
: Antimicrobial Resistance
Motor Neuron Disease
Page
18 December 2023
Read more
: Motor Neuron Disease
Previous Page
1
2
3
4
…
42
Next Page
Close Modal
